🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It is such an honor to be an ASCO featured voice and take over ASCO page for their new #Ai initiative. Proud to represent IMG Oncologists Hem-Onc Fellows Network and Mayo Clinic Comprehensive Cancer Center and Mayo Clinic #ASCO25 Please try the ASCO Guidelines Assistant!

Thrilled to present our case series on 177Lu-Dotatate in R/M olfactory neuroblastoma at #ASCO25! ORR: 43% (RECIST 1.1), 33% (mPERCIST) DCR: 100% Median PFS: 17.0 mo (vs 4.2 prev lines) PFS longer vs. prior lines (HR 0.197, p<0.001) Promising, well-tolerated option for SSTR2+ ONB

Helpful tips and grounded perspectives at the #ASCO25 “Finding Your First Job” panel — thank you to the speakers. ASCO TECAG Ana I. Velázquez Mañana, MD, MSc, FASCO Noha N. Soror, MD, MSc. 𓂀 Arthi Sridhar Dionisia Quiroga, DO, PhD

Honored to join this fantastic panel alongside incredible colleagues! We covered key topics like when to start your job search, how to navigate applications, interviews, job talks, and more. Grateful to ASCO and ASCO TECAG for creating space for these important conversations.

👩🏽‍⚕️👨🏾‍⚕️💼 Incredible insights at today’s #ASCO25 panel on Finding Your First Job — from interviews to negotiations, these powerhouse oncologists shared the tips they wish they knew during job hunt season. Grateful for the wisdom and candor from Ana I. Velázquez Mañana, MD, MSc, FASCO Noha N. Soror, MD, MSc. 𓂀 Arthi Sridhar

Has there ever been a more girl boss ASCO TECAG panel? 💪💪💪 Noha N. Soror, MD, MSc. 𓂀 Ana I. Velázquez Mañana, MD, MSc, FASCO Arthi Sridhar Dionisia Quiroga, DO, PhD

Hematology/Oncology Resident Sarah Premji, MD discusses her #ASCO25 abstract: "Estrogen receptor expression in residual #BreastCancer following neoadjuvant chemotherapy." Read the abstract here: ascopubs.org/doi/10.1200/JC…

Yesterday’s update of #SOFT #TEXT made me think of an important point. Be very careful (or just don’t) tell a premenopausal pt “your recurrence risk is X”- whatever their Oncotype says it is. That is in the next 9 years!!! A premenopausal patient wants to live 60 years.! Oncotype

This 👇 is such an important point! #MBC #bcsm

Wrapping up an incredible #ASCO25 inspired by the science, and so grateful for the chance to reconnect and make memories with amazing friends and colleagues. Until next time! ✨ ASCO TECAG IMG Oncologists Dr. Nagla Abdel Karim Nazli Dizman Dawood Findakly, MD, FACP Dionisia Quiroga, DO, PhD Kelly Meza, MD

Thrilled to officially join the 2025–2026 ASCO Trainee & Early Career Advisory Group (ASCO TECAG )! 💼🌟 This powerhouse team brings together trainees from across the country united by a shared mission: championing the next generation of oncologists. Grateful for the

Join a small group discussion on HER2-ultralow scoring, AI-assisted pathology, and T-DXd (Enhertu) response in this patient cohort. Dionisia Quiroga, DO, PhD is excels at translating complex science into clear, accessible language. #bcsm

How do we currently define HER2 status and what can AI + other technologies do to help us identify those who benefit from HER2-targeted tx? Join me and GRASP for a discussion on HER2-ultra low breast cancer and updates from #ASCO25 Thurs 6/12! #bcsm

👏 Congrats to Dr. Audrey Sigmund (Audrey Sigmund) on being selected for the 2025–2026 ASCO Leadership Development Program: Education Scholars! Only 12 oncologists nationwide are chosen each year—an incredible honor recognizing her leadership in oncology education. 🌟

Had a chance to speak with CancerNetwork alongside Eric K. Singhi, MD, MinhTri Nguyen, MD (he/him), Nerea Lopetegui-Lia, MD and Marc Braunstein, MD, PhD, FACP about one of the most underdiscussed—and overwhelming—periods in our careers: preparing for the boards while transitioning from fellowship to faculty. The facts: 📚

I could not have summarized it better Nicholas Hornstein Preparing for boards and navigating fellow-to-attending transition is intense — but staying connected makes it lighter! Lean on family, friends, mentors, colleagues (old and new). It makes all the difference! Hem-Onc Fellows Network

🚨Proud to share our publication in JCO Oncology Practice 🧵International Medical Graduates (IMGs) are underrepresented in invited faculty roles at #ASCO Annual Meetings, despite their contributions to original research! Toni Choueiri, MD Nazli Dizman Ziad Bakouny, MD, MSc IMG Oncologists gilberto lopes

🚴‍♀️On 8/2, I’ll be cycling 50 miles with Pelotonia to raise funds for cancer research. 💯% of donations go directly to research #EndingCancer #OneGoal Please consider supporting my ride pelotonia.org/profile/NL9672…

Happy July to all new fellows! 🎉 Fionnuala Crowley and I are excited to share our new article: Balancing the Scales: Real-Life Fellows’ Perspectives on Navigating Work-Life Balance in Oncology Training and Beyond | ASCO Connection connection.asco.org/do/balancing-s… We truly enjoyed writing

Adverse events in patients treated with neoadjuvant chemo/immunotherapy for triple negative breast cancer: results from seven academic medical centers link.springer.com/article/10.100… In this large real-world study of 415 patients with early-stage or locally advanced triple-negative